Finance

Beta
Lists
VNRX:NYSEAMERICAN
VolitionRX Ltd
$1.79
-10.50%
(-0.21) 1D
$1.65
-7.82% (-0.14)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VNRX...
Open
$1.98
High
$2.03
Low
$1.75
Mkt. cap
15.44M
Avg. vol.
539.46K
Volume
474.80K
52-wk high
$3.26
52-wk low
$0.13
EPS
-$4.22
Beta
1.04
Shares outstanding
8.63M
No. of employees
75
Open
$1.98
High
$2.03
Low
$1.75
Mkt. cap
15.44M
Avg. vol.
539.46K
Volume
474.80K
52-wk high
$3.26
52-wk low
$0.13
EPS
-$4.22
Beta
1.04
Shares outstanding
8.63M
No. of employees
75
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to VNRX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for VNRX in the last 3 months.
Highest
Current $1.79
$24.00 (+1,240.78%)
Average
$22.00 (+1,129.05%)
Lowest
$20.00 (+1,017.32%)
News stories
From sources across the web
About VolitionRX Ltd
CEOCameron Reynolds
Employees75
Founded2010
HeadquartersHenderson, Nevada, United States
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
406.69K
627.28K
447.03K
985.08K
Cost of goods sold
-
-
-
450.13K
Cost of revenue
-
-
-
450.13K
Research and development expenses
2.72M
2.29M
2.47M
2.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.98M
3.44M
2.80M
3.48M
Operating expense
6.70M
5.73M
5.27M
6.33M
Total operating expenses
6.70M
5.73M
5.27M
6.78M
Operating income
-6.30M
-5.10M
-4.82M
-5.80M
Other non operating income
431.91K
564.47K
-415.50K
232.59K
EBT including unusual items
-6.31M
-5.41M
-6.30M
-6.70M
EBT excluding unusual items
-6.31M
-5.41M
-6.30M
-5.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.28M
-5.38M
-6.27M
-6.66M
Net profit margin
-1,545.18%
-857.41%
-1,402.76%
-676.57%
Earnings per share
-1.31
-1.06
-0.91
-0.84
Interest and investment income
160.00
160.00
122.00
16.00
Interest expense
-448.66K
-873.43K
-1.07M
-125.84K
Net interest expenses
-448.50K
-873.27K
-1.07M
-125.83K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.05M
-4.85M
-4.59M
-5.59M
Gain or loss from assets sale
-330.00
660.00
-2.16K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more